Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has issued an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has announced the composition of its board of directors, which includes both executive and independent non-executive directors. The board has established four committees, each with specific roles and responsibilities, to enhance the company’s governance and strategic decision-making processes.
The most recent analyst rating on (HK:0874) stock is a Buy with a HK$21.50 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a pharmaceutical company based in the People’s Republic of China. It operates in the healthcare industry, focusing on the development, production, and distribution of pharmaceutical products.
YTD Price Performance: 3.65%
Average Trading Volume: 1,769,764
Technical Sentiment Signal: Buy
Current Market Cap: HK$42.86B
For a thorough assessment of 0874 stock, go to TipRanks’ Stock Analysis page.